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Nerve growth factor induces innervation and epidermal
hyperplasia in in£ammatory skin diseases like psoriasis.
Nerve growth factor production by keratinocytes is in-
creased in the in£ammatory lesions. Nerve growth
factor induces histamine release from mast cells. We
examined the in vitro e¡ects of histamine on nerve
growth factor production in human keratinocytes. His-
tamine enhanced nerve growth factor secretion,
mRNA expression, and promoter activity in keratino-
cytes. Two TPA-response elements on the nerve growth
factor promoter were responsible for the activation by
histamine. Histamine enhanced transcriptional activity
and DNA binding of activator protein 1 at the twoTPA-
response elements. It shifted theTPA-response-element-
binding activator protein 1 composition from c-Jun
homodimers to c-Fos/c-Jun heterodimers. Histamine
transiently induced c-Fos mRNA expression, which
was not detectable in unstimulated keratinocytes,
whereas c-Jun mRNA expression was constitutive and
was not altered by histamine. Histamine-induced en-
hancement of nerve growth factor secretion, promoter
activity, activator protein 1 transcriptional activity, and
c-Fos expression was suppressed by H1 antagonist pyri-
lamine, protein kinase C inhibitor calphostin C, and
PD98059, an inhibitor of mitogen-activated protein ki-
nase kinase 1. Histamine induced the translocation of
protein kinase C activity from cytosol to membrane,
which was suppressed by phospholipase C inhibitor
U73122. It stimulated the phosphorylation of extra-
cellular signal-regulated kinase, which was blocked by
pyrilamine, calphostin C, and PD98059. These results
suggest that histamine may enhance nerve growth
factor production by inducing c-Fos expression in
keratinocytes. These e¡ects may be mediated by the
H1-receptor-induced signaling cascade of phospholi-
pase Cprotein kinase Cmitogen-activated protein
kinase kinase 1extracellular signal-regulated kinase.
Key words: activator protein 1/c-Fos/extracellular signal-regu-
lated kinase/H1 receptor/protein kinase C. J Invest Dermatol
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N
erve growth factor (NGF) plays an important role
in the development of in£ammatory skin diseases
like psoriasis, atopic dermatitis, or allergic contact
dermatitis (Raychaudhuri et al, 1998; Kinkelin
et al, 2000; Toyoda et al, 2002). In these skin dis-
eases, NGF production in keratinocytes is enhanced (Raychaud-
huri et al, 1998; Kinkelin et al, 2000; Toyoda et al, 2002). NGF
potentiates the proliferation of neurons, which may result in hy-
perinnervation and itch sensation in in£ammatory skin diseases
(Kinkelin et al, 2000). NGF also enhances the growth of keratino-
cytes having the high a⁄nity NGF receptor trkE (Di Marco et al,
1993; Pincelli et al, 1994), which may lead to epidermal hyperplasia
associated with psoriasis or atopic dermatitis (Toyoda et al, 2002).
NGF also promotes the histamine release of mast cells (Bruni
et al, 1982; Pearce and Thompson, 1986; Matsuda et al, 1991;
Horigome et al, 1993; 1994). In the early phases of psoriasis or ato-
pic dermatitis, mast cells are increased in the dermis (Jiang et al,
2001; Alenius et al, 2002). Mast cell-derived histamine induces
keratinocytes to produce various in£ammatory cytokines or
chemokines such as interleukin-6 or interleukin-8 (Kohda et al,
2002). It is thus plausible that histamine may also induce NGF
production in keratinocytes. A previous study reported that his-
tamine in vitro enhanced NGF production by murine transformed
keratinocytes PAM212 and 3T3 ¢broblasts (Matsuda et al, 1998). It
is unknown, however, what level of NGF production, i.e. trans-
lational or transcriptional, histamine may potentiate. In addition,
previous studies did not show intracellular signaling events
responsible for the NGF potentiation by histamine.
Histamine binds to cell surface receptors coupling to guanine
nucleotide-binding protein (G-protein) and induces various in-
tracellular signaling pathways. Four isotypes of histamine recep-
tors have been identi¢ed: H1, H2, H3, and H4 receptors (Oda
et al, 2000). H1 receptor is linked to the activation of phospholi-
pase C (PLC), which generates diacylglycerol activating protein
kinase C (PKC) (Megson et al, 2001). Stimulation of H2 receptor
mostly activates adenylate cyclase, which generates a cAMP signal
that activates protein kinase A; however, H2 receptor is also
linked to PLC in certain cell types (Del Valle and Ganz, 1997).
H3 and H4 receptors are coupled to the inhibition of adenylate
cyclase (Coge et al, 2001). These histamine-receptor-mediated
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signals regulate cytokine or chemokine gene expression in target
cells (Kanda andWatanabe, 2002).
In this study, we examined the e¡ects of histamine on NGF
production in cultured human keratinocytes.We found that his-
tamine potentiates NGF production in keratinocytes via H1 re-
ceptors. We further examined the precise mechanism for this
e¡ect focusing on the histamine-induced intracellular signaling
pathways.
MATERIALS AND METHODS
Reagents Histamine dihydrochloride, cimetidine, pyrilamine, and
calphostin C were obtained from Sigma (St Louis, MO). Thioperamide
maleate was from Biomol Research Laboratories (Plymouth Meeting,
PA). 1-[6-((17b-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]-1H-pyrrole-2,
5-dione (U73122), N-[[2-(p-bromocinnamylamino)ethyl]-5-isoquinol-
inesulfonamide (H-89), and 4-(3-chloroanilino)-6, 7-dimethoxy-
quinazoline (AG1478) were obtained from Calbiochem (La Jolla, CA).
Recombinant human tumor necrosis factor a was from R&D Systems
(Minneapolis, MN). Antibodies used in the electrophoretic mobility shift
assay (EMSA) were from Santa Cruz Biotechnology (Santa Cruz, CA).
Culture of keratinocytes Human neonatal foreskin keratinocytes were
cultured in serum-free KGM medium (Clonetics, Walkersville, MD)
consisting of basal medium MCDB153 supplemented with 0.5 mg per ml
hydrocortisone, 5 ng per ml epidermal growth factor, 5 mg per ml insulin,
and 0.5% bovine pituitary extract. The cells in third passage were used.
NGF secretion Keratinocytes (2104 per well) were seeded in triplicate
into 24-well plates in 1 ml KGM and adhered overnight; the medium was
then changed to basal KBM depleted of hormones, growth factors, and
bovine pituitary extract, and the cells were incubated for 24 h. The
medium was removed and the cells were incubated with histamine in
KBM for 24 h. The supernatants were assayed for NGF by ELISA
(Promega, Madison,WI).
RT-PCR Keratinocytes were incubated as above for indicated periods,
and cellular mRNA was extracted using an mRNA puri¢cation kit
(Pharmacia, Uppsala, Sweden) according to the manufacturer’s
instruction. cDNA was made from mRNA samples as described
previously (Tjandrawinata et al, 1997). Primers for ampli¢cation and the
sizes of respective PCR products were as follows: NGF, 50 -CACACTGAG-
GTGCATAGCGT-30 and 50 -TGATGACCGCTTGCTCCTGT-30 for
352 bp; c-Fos, 50 -GGCTTCAACGCAGACTACGAGG-30 and 50 -CTCCT-
GTCATGGTCTTCACAACG-30 for 340 bp; c-Jun, 50 -TTCACCTTCTC-
TCTAACTGC-30 and 50 -TCACTCACTGAGCGCTCTTC-30 for 580 bp;
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 50 -GCAGGGGG-
GAGCCAAAAGGG-30 and 50 -TGCCAGCCCCAGCGTCAAAG-30 for
566 bp (Lane et al, 1998; Risse-Hackl et al, 1998; Iannone et al, 2002; Kanda
and Watanabe, 2002). PCR involved one denaturing cycle of 951C for
3 min, 30 cycles of denaturation at 951C for 30 s, annealing at 581C for
30 s, and extension at 721C for 30 s, and a ¢nal extension at 721C for 3
min. The PCR products were analyzed by electrophoresis on 2.5%
agarose gels and stained with ethidium bromide, viewed by ultraviolet
light. Densitometric analysis was performed by scanning the bands into
Photoshop and performing densitometry with NIH Image Software.
Plasmids and transfections The ¢re£y luciferase reporter plasmids
driven by human NGF promoter (^600/þ 250 bp relative to the
transcriptional start site) were constructed by PCR and insertion into
pGL3 basic vector (Promega) as described previously (Cartwright et al,
1992), and are denoted pNGF luc. Site-speci¢c mutation of the promoter
was created by multiple rounds of PCRusing primers with altered bases as
described previously (Li and Kolattukudy, 1994). p4TPA response
element 1 (TRE1)-TATA-luc and p4TRE2-TATA-luc were constructed
by inserting four copies of TRE1 (50 -GCGTGTGACTCAGGAGT-30,
consensus sequence underlined) or TRE2 (50 -AGCGGTGAGTCA-
GGCTG-30) from human NGF promoter in front of the TATA box
upstream of ¢re£y luciferase reporter as described previously (Kanda and
Watanabe, in press). Transient transfections were performed with E¡ectene
(Qiagen, Tokyo, Japan) as described previously (Zellmer et al, 2001). The
e⁄ciency of transfection into keratinocytes by this method was
28.5%73.1% (mean7SEM, n¼ 9) as determined by £ow cytometry
using b-galactosidase vector. E¡ectene produced a higher transfection
e⁄ciency than Lipofectin (8.1%71.2%), Lipofectamine (9.5%71.1%), or
polybrene-dimethylsulfoxide (8.5%70.9%), and thus was adopted in this
study. Keratinocytes were plated in 10 cm dishes and grown to about 60%
con£uence. Twenty-four hours before the transfection, the medium was
changed to KBM. Keratinocytes were incubated for 6 h with 5 mg of
pNGF luc or p4TRE1-TATA-luc or p4TRE2-TATA-luc and 1 mg of
Rous sarcoma virus b-galactosidase vector (pRSV-b-gal), premixed with
enhancer, transfection bu¡er, and E¡ectene. The transfected cells were
washed and incubated in KBM for 18 h and then treated with histamine.
After 6 h, cell extracts were prepared and luciferase activities were quanti-
¢ed using the luciferase assay system (Promega). The same cell extracts
were assayed for b-galactosidase activity using the chemiluminescent
Galacto-Light kit (Tropix, Bedford, MA). All readings were taken using a
Lumat 9501 luminometer (Berthold, Wildbach, Germany). The results
obtained in each transfection were normalized for b-galactosidase activity
and expressed as relative luciferase activity.
EMSA EMSAwas performed as described previously (Cartwright et al,
1992). The probes used were 32P-labeled annealed double-stranded DNA
containing TRE1 or TRE2 from human NGF promoter. The sequence of
theTRE1probe is 50 -ATTTGGAGCGTGTGACTCAGGAGTACGGGAG-30
(consensus sequence underlined) and that of the TRE2 probe is 50 -
GGAGCGCAGCGGTGAGTCAGGCTGCCCCGAG-30. For gel shift
assays, 2^5 mg of nuclear protein extracts were incubated at room
temperature for 5 min with a mixture containing 6 mM HEPES (pH 7.9),
0.4 mM ethylenediamine tetraacetic acid (EDTA), 125 mM KCl, 10%
glycerol, 0.05 mg per mL poly dI-dC, 1 mM dithiothreitol, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, 10 mM NaF,
50 mg per ml aprotinin, 50 mg per ml leupeptin. One nanogram of
labeled probe was added and the reactions were incubated for another
20 min. In antibody supershift experiments, the nuclear extracts were
preincubated with various antibodies for 30 min before the addition of
probe. Reactions were then fractionated on a nondenaturing 5%
polyacrylamide gel, and visualized with phosphorimager (Molecular
Dynamics, Sunnyvale, CA).
Western blot analysis The dual threonine/tyrosine phosphorylation of
extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal
kinase (JNK), and p38 mitogen-activated protein kinase (MAPK) was
assessed by western blot as described previously (Gee et al, 2002).
Keratinocytes were incubated with 10^6 M histamine or 10 ng per mL
tumor necrosis factor a for 10 min. The cells were lyzed with lysis bu¡er
(50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Triton X-100,
1.5 mM MgCl2, 100 mM NaF, 100 mM sodium orthovanadate, and 1 mM
ethyleneglycol-bis(b-aminoethyl ether)-N,N,N0,N0-tetraacetic acid (EGTA,
pH 7.7)) and centrifuged for 20 min at 14,000 g at 41C. The supernatant
proteins were subjected to sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred to a nitrocellulose
membrane. The membrane was blocked and incubated with antiphospho-
ERK1/2 or antiphospho-JNK antibodies (Santa Cruz Biotechnology) or
antiphospho-p38 antibody (New England Biolabs, Mississauga, Ontario,
Canada), followed by peroxidase-conjugated secondary antibodies (Bio-
Rad, Hercules, CA). The blots were developed with an enhanced
chemiluminescence kit (Amersham, Arlington Heights, IL). The blots
were stripped and reprobed with rabbit polyclonal antibodies speci¢c for
each of unphosphorylated ERK1/2, JNK, and p38 MAPK (Santa Cruz
Biotechnology), as described above.
Assays of PKC PKC activity was analyzed as described previously
(Migliaccio et al, 1998). Keratinocytes were incubated with 10^6 M
histamine for 10 min. The cells were harvested and homogenized in a
bu¡er containing 20 mMTrisHCl (pH 7.4), 2 mM EDTA, 10 mM EGTA,
250 mM sucrose, 5 mM dithiothreitol, 1 mM phenylmethyl-
sulfonyl £uoride, and 0.24 mM leupeptin. Nuclei and debris were removed
from the samples by centrifugation (500 g, 5 min) and this post
nuclear fraction was then centrifuged (105,000 g, 90 min). The super-
natant was saved as the cytosolic fraction. The pellet was homogenized in
the same bu¡er, except for containing 0.1% Triton X-100. The samples
were mixed continuously for 1 h at 41C and then centrifuged as described
above. This supernatant was saved as the membrane fraction. The cytosolic
or membrane fractions were loaded onto columns packed with
diethylaminoethyl-sephacel resin and were washed extensively with a
solution of 20 mM TrisHCl (pH 7.4), 20 mM NaCl, 0.5 mM EDTA,
0.5 mM EGTA, and 10 mM 2-mercaptoethanol. PKC was eluted with the
same bu¡er except that the NaCl concentration was increased to 100 mM.
Aliquots of puri¢ed PKC from cytosolic or membrane fractions were
assayed for protein contents using the Bio-Rad protein determination
assay. PKC activity was assessed using a reaction mixture containing
20 mM TrisHCl (pH 7.4), 8 mM MgCl2, 16 mM ATP, [g-
32P]ATP, and
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200 mg per ml histone III-S at 301C for 3 min. Activity was determined in
the presence or absence of 100 mM CaCl2, 8 mg per ml phosphatidyl serine,
and 2 mg per ml diolein. Samples were ¢ltered withWhatman GF/C ¢lters,
and 32P incorporation into lysine-rich histone was quanti¢ed by liquid
scintillation.
Measurement of histamine release Keratinocytes (2104 per well)
were seeded into 24-well plates in KGM, adhered overnight, and
incubated with KBM for 24 h. The medium was replaced with fresh
KBM, and the cells were incubated for 24 h. The supernatant histamine
amount was measured by ELISA (Cosmo Bio,Tokyo, Japan).
RESULTS
Histamine enhanced NGF secretion in keratinocytes
Keratinocytes constitutively secreted a low amount of NGF
(21.572.8 pg per ml, mean7SEM, n¼ 5), and the secretion
was concentration-dependently increased by histamine; the
stimulatory e¡ect of histamine was manifested at 10^7 M and
was maximized at 10^6 M, which increased the secretion 4.5-fold
of controls (Fig 1). The stimulatory e¡ect of histamine was not
suppressed by pertussis toxin, indicating that the e¡ect may be
mediated via pertussis-toxin-resistant G-proteins. H1 receptor
antagonist pyrilamine blocked the stimulatory e¡ect of
histamine (Fig 1) whereas H2 antagonist cimetidine (Fig 1) or
H3 and H4 antagonist thioperamide (data not shown) did not.
These results suggest that H1 receptor but not H2, H3, or H4
receptors may mediate histamine-induced enhancement of NGF
secretion in keratinocytes. As 10^6 M of histamine was optimal
for NGF induction, this concentration was used in the following
experiments.
As examined by ELISA, constitutive histamine secretion by
keratinocytes was 9.7570.83 nM (mean7SEM, n¼ 5), which
was less than the threshold (100 nM) for NGF induction (Fig 1).
Pyrilamine, cimetidine, and thioperamide did not reduce the
constitutive NGF secretion in the absence of exogenous
histamine (data not shown). This suggests that endogenous
histamine secreted by keratinocytes may not contribute to NGF
secretion. We next examined if histamine may enhance NGF
mRNA expression in keratinocytes.
Histamine increased NGF mRNA levels At 3 h of
incubation, histamine increased the NGF mRNA level 6.1-fold
of controls, which was reversed by pyrilamine but not by
cimetidine or pertussis toxin (Fig 2). Thus histamine increased
NGF production via H1 receptors at pretranslational level. We
then examined if histamine may enhance NGF promoter
activity in keratinocytes.
Histamine enhanced NGF promoter activity It is reported
that human NGF gene contains two TREs, TRE1 (^62/^56 bp)
and TRE2 (þ 35/þ41 bp), and these may act as enhancer
elements for NGF transcription (Cartwright et al, 1992) (Fig 3a).
We transiently transfected NGF promoter (^600/þ 250 bp)
linked to luciferase reporter into human keratinocytes.
Histamine treatment increased NGF promoter activity 5.1-fold
of controls, and the e¡ect was blocked by pyrilamine (Fig 3b).
The mutation of TRE1 or TRE2 each reduced the basal
promoter activity and histamine-induced enhancement of the
activity. The mutation of both TRE completely abrogated the
basal and histamine-induced promoter activities. These results
suggest that both TRE1 and TRE2 may be required for basal
and histamine-induced NGF promoter activities. We then
analyzed if histamine may enhance transcriptional activities
dependent onTRE1 or TRE2.
Histamine enhanced transcription from TRE1 or
TRE2 Keratinocytes were transiently transfected with
luciferase reporter linked to four repeats of TRE1 or TRE2 in
front of the TATA box. Histamine increased the TRE1- or
TRE2-dependent transcriptional activities, and the e¡ects were
reversed by pyrilamine (Fig 4).
Figure1. Dose dependence for the e¡ects of histamine on NGF
secretion and the inhibition by H1 or H2 receptor antagonists or
pertussis toxin on the e¡ects of histamine. Keratinocytes were preincu-
bated with pertussis toxin (PTX; 16 h, 100 ng per ml), pyrilamine (PR), or
cimetidine (CM) (each 10^5 M, 30 min), and then incubated with indicated
doses of histamine for 24 h in the presence of the inhibitors. The culture
supernatants were assayed for NGF.Values are mean7SD of triplicate cul-
tures. po0.05 versus control cultures, by one-wayANOVAwith Dunnett’s
multiple comparison test.The data shown in the ¢gure are representative of
¢ve separate experiments.
Figure 2. The e¡ects of histamine on NGF mRNA level in kerati-
nocytes. Keratinocytes were preincubated with pertussis toxin (PTX;
16 h, 100 ng per ml), pyrilamine (PR), or cimetidine (CM) (each 10^5 M,
30 min), and then incubated with 10^6 M histamine (HA). After 3 h,
mRNA was isolated and RT-PCR was performed. The intensity of the
band for NGF was corrected to that for GAPDH. The lower graph shows
the corrected intensities relative to that in control cells cultured with med-
ium alone (set as 1.0). The results shown in the ¢gure are representative of
¢ve separate experiments.
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Histamine induced c-Fos/c-Jun binding toTRE It is known
that TRE is mostly bound by transcription factor activator
protein 1 (AP-1) (Allegretto et al, 1990). We then examined if
histamine may enhance DNA binding of AP-1 at TRE on the
NGF promoter. At 1 h of incubation, histamine increased
the amount of DNAprotein complex with TRE1 probe, and
the e¡ect was reversed by pyrilamine (Fig 5, lane 4). This
suggests that histamine may increase transcription factor binding
to TRE in keratinocytes via H1 receptors. In unstimulated
keratinocytes, anti-c-Jun did but anti-c-Fos antibody did not
supershift the complex (Fig 5, lanes 5, 6), whereas in histamine-
stimulated keratinocytes both antibodies supershifted the
complex (Fig 5, lanes 7, 8). Antibodies against the other Fos
family (FosB, Fra-1, Fra-2) or Jun family (JunB, JunD) proteins
did not supershift the complexes by nuclear extracts from
unstimulated or histamine-stimulated keratinocytes (data not
shown). These results suggest that histamine may shift the AP-1
composition from c-Jun homodimers to c-Fos/c-Jun hetero-
dimers at TRE1. Similar results were obtained by using theTRE2
probe (data not shown).
Histamine induced c-Fos expression in keratinocytes We
then examined if histamine may enhance c-Fos or c-Jun
expression in keratinocytes. Histamine rapidly and transiently
induced c-Fos mRNA. In unstimulated cells, c-Fos mRNA
was undetectable; however, in histamine-stimulated cells, the
expression was induced at 15 min, maximized at 30 min,
reduced at 1 h, and disappeared at 3 h (Fig 6). c-Jun mRNA
expression was constitutively detectable and was not enhanced
by histamine. The results indicate that histamine-induced NGF
production may be mainly attributable to the induction of c-Fos
expression.
PLC^PKC^MAPK kinase 1 (MEK1)^ERK pathway is
involved in histamine-induced NGF production and c-Fos
expression Histamine is known to induce various intracellular
signaling pathways: the PLCPKC pathway leading to the
activation of ERK (Megson et al, 2001) or the adenylate
cyclaseprotein kinase A pathway (Shayo et al, 1997). We thus
tried to identify the signaling pathway involved in histamine-
induced enhancement of NGF production. PKC inhibitor
calphostin C completely suppressed histamine-induced enhance-
ment of NGF promoter activity (Fig 7a), NGF secretion
(Fig 7b), TRE1-dependent transcriptional activity (Fig 7c),
and c-Fos expression (Fig 7d). Histamine-induced c-Fos
Figure 3. The e¡ects of histamine on the activities of wild-type or
mutated NGF promoters. (a) Schematic representation of human NGF
promoter. The locations of cis-elements are shown with their sequences,
and substituted bases for mutation are indicated in italics. The nucleotide
positions are relative to the transcriptional start site. (b) Keratinocytes were
transiently transfected with wild-type (WT) or mutated pNGF luc to-
gether with pRSV-b-gal. The cells were preincubated with or without 10^
5 M pyrilamine (PR) for 30 min, and then treated with 10^6 M histamine
(HA). After 6 h, relative luciferase activities were analyzed. The data are
mean7SEM of four separate experiments. Values at the right indicate the
fold induction versus basal promoter activity. po0.05 versus control values,
wpo0.05 versus values with histamine alone, by one-way ANOVA with
Sche¡e’s multiple comparison test.
Figure 4. The e¡ects of histamine onTRE-dependent transcription.
Keratinocytes were transiently transfected with p4TRE1-TATA-luc or
p4TRE2-TATA-luc or enhancerless pTATA-luc, together with pRSV-
b-gal. The cells were preincubated with 10^5 M pyrilamine (PR) for 30
min, and then incubated with 10^6 M histamine (HA). After 6 h, relative
luciferase activities were analyzed. The results represent mean7SEM of
four separate experiments. Values at the right indicate the fold induction
versus basal activity. po0.05 versus control values, wpo0.05 versus values
with histamine alone, by one-way ANOVA with Sche¡e’s multiple com-
parison test.
Figure 5. The e¡ect of histamine on transcription factor binding to
TRE. Keratinocytes were preincubated with 10^5 M pyrilamine (PR) for
30 min, and then incubated with 10^6 M histamine (HA) for 60 min. Nu-
clear extracts were prepared and incubated with TRE1-containing probe.
In supershift assays, nuclear extracts were incubated with antibodies against
c-Fos or c-Jun for 30 min before the addition of the probe. The asterisks
indicate the supershifted complexes. The results shown in the ¢gure are re-
presentative of four separate experiments.
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expression was also completely inhibited by PD98059, which
selectively blocks ERK activity by inhibiting MEK1 to phos-
phorylate ERK1/2 (Fig 7d). PD98059 also suppressed histamine-
induced enhancement of NGF promoter activity (Fig 7a), NGF
secretion (Fig 7b), and TRE1-dependent transcriptio-
nal activity (Fig 7c) by 60%^65%. These results suggest
the requirement of PKC and ERK for histamine-induced
enhancement of NGF production. In contrast, histamine-
induced NGF promoter activation, NGF secretion, TRE1-
dependent transcriptional activity, and c-Fos expression were
not suppressed by protein kinase A inhibitor H-89, indicating
that protein kinase A may be dispensable for the histamine-
induced e¡ects. We then examined if histamine may activate
PKC or ERK in keratinocytes. In unstimulated keratinocytes,
most PKC activity resided in the cytosolic fraction (Fig 8a). At
10 min after histamine treatment, PKC activity in the membrane
fraction was enhanced, indicating the membrane translocation
of PKC. Pyrilamine and PLC inhibitor U73122 suppressed
the histamine-induced enhancement of PKC activity in the
membrane whereas cimetidine and pertussis toxin did not
(Fig 8b). These results suggest that histamine-induced
membrane translocation of PKC may be mediated via H1
receptor and PLC but may be independent of H2 receptor and
insensitive to pertussis toxin. ERK is known to be activated by
MEK1 via dual phosphorylation on threonine and tyrosine
residues (Widmann et al, 1999). We thus examined the
phosphorylation status of ERK after histamine treatment. At 10
min, histamine induced dual phosphorylation of ERK1 (44
kDa) and ERK2 (42 kDa) (Fig 9a), and the phosphorylation
was suppressed by calphostin C, PD98059, and pyrilamine,
indicating that histamine-induced ERK activation may require
PKC, MEK1 activity and may be mediated via H1 receptor.
Recent studies have demonstrated that certain G-protein-
coupled receptors activate ERK via transactivation of epidermal
growth factor receptor tyrosine kinase (Zwick et al, 1999).
This possibility is rather unlikely in histamine-stimulated
keratinocytes, however, as AG1478, an inhibitor of epidermal
growth factor receptor tyrosine kinase, did not block histamine-
induced ERK phosphorylation (Fig 9a). In contrast to ERK,
histamine did not stimulate the dual phosphorylation of other
MAPKs, JNK, and p38 MAPK in keratinocytes (Fig 9b, c).
DISCUSSION
In this study, histamine enhanced NGF production in human
keratinocytes via H1 receptors, which is consistent with previous
studies on rat astrocytes (Lipnik-Strangelj et al, 1998; Lipnik-
Strangelj and Carman-Krzan, 2000; 2001). Histamine stimulated
NGF transcription in keratinocytes by enhancing transcriptional
activity of AP-1. Histamine induced rapid and transient c-Fos
mRNA expression. The induced c-Fos may heterodimerize with
c-Jun and the heterodimers may bind to twoTREs on NGF pro-
moter and drive NGF transcription. On the other hand, c-Jun
homodimers appeared to bind toTRE in unstimulated keratino-
cytes. It is reported that c-Fos/c-Jun heterodimers much more
avidly bind to DNA and have much higher transcriptional acti-
vity than c-Jun homodimers (Allegretto et al, 1990; Suzuki et al,
1991). Thus histamine may enhance AP-1 binding and transcrip-
tional activity by inducing c-Fos expression and thus shifting
Figure 6. The e¡ects of histamine on c-Fos or c-Jun mRNA expres-
sion in keratinocytes. Keratinocytes were incubated with 10^6 M hista-
mine. At indicated time-points, mRNA was isolated and RT-PCR was
performed. The results shown in the ¢gure are representative of ¢ve sepa-
rate experiments.
Figure 7. The inhibition by several
signal inhibitors of histamine-induced
NGF promoter activity (a), NGF secre-
tion (b), TRE-dependent transcriptional
activity (c), and c-Fos mRNA expres-
sion (d). (a), (c) Keratinocytes were transi-
ently transfected with pNGF luc (a) or
p4TRE1-TATA-luc (c), together with
pRSV-b-gal, then preincubated with 10^6 M
H-89, 10^6 M calphostin C (CalC), or 10^5 M
PD98059 for 30 min, and then incubated
with 10^6 M histamine (HA). After 6 h, rela-
tive luciferase activities were analyzed. (b),
(d) Keratinocytes were preincubated with in-
hibitors, and then incubated with histamine
as above. Culture supernatants were har-
vested after 24 h whereas mRNA was ex-
tracted after 30 min. In (a), (b), (c), values
are mean7SEM of ¢ve separate experi-
ments. po0.05 versus control values, wpo
0.05 versus values with histamine alone, by
one-way ANOVA with Sche¡e’s multiple
comparison test. The results shown in (d) are
representative of ¢ve separate experiments.
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AP-1 composition from c-Jun homodimers to c-Fos/c-Jun hetero-
dimers.
Histamine-induced c-Fos expression was mediated via ERK
activation, which is consistent with the previous study (Megson
et al, 2001). c-fos promoter contains serum response element where
ternary complex factors like Elk1 are binding (Janknecht et al,
1995; Soh et al, 1999). It is known that ERK-mediated phosphory-
lation of Elk1 promotes its transcriptional activity (Marais et al,
1993). It is thus anticipated that Elk1 phosphorylation by ERK
may be involved in histamine-induced c-Fos expression. Hista-
mine-induced activation of ERKwas dependent on H1 receptor,
PKC, and MEK1 (Fig 9a). It is reported that the activation of H1
receptor leads to the stimulation of PLCb, which generates dia-
cylglycerol that activates PKC (Hill et al, 1997). PKC is known
to phosphorylate and activate c-Raf (Kolch et al, 1993), and the
activated c-Raf may further phosphorylate and activate MEK1
catalyzing ERK phosphorylation. Thus the activation of H1 recep-
tor may trigger the signaling cascade of PLCPKCc-
RafMEK1ERK, and resultantly induce c-fos transcription.
The activation of this cascade is insensitive to pertussis toxin, in-
dicating that pertussis-toxin-insensitive G-proteins like Gq/11 may
link H1 receptors to PLC in keratinocytes. In certain cell types,
H2 receptor, as well as H1 receptor, is known to be linked to
PLC activation (Del Valle and Ganz, 1997). In keratinocytes, how-
ever, H2 receptor may not be functionally linked to the
PLCPKC pathway as cimetidine did not inhibit PKC activation
by histamine (Fig 8b).
In monocytic U937 cells, histamine induces c-fos transcription
by stimulating H2 receptor linked to the adenylate cyclase
protein kinase A pathway (Shayo et al, 1997). c-fos promoter con-
tains cAMP response element, where cAMP-response-element-
binding protein binds and drives c-fos transcription (Janknecht
et al, 1995). The transcriptional activity of cAMP-response-
element-binding protein is promoted via phosphorylation by
cAMP-dependent protein kinase A (Lalli and Sassone-Corsi,
1994). Protein kinase Awas dispensable for histamine-induced c-
Fos expression in keratinocytes, however (Fig 7). Thus the me-
chanism for c-Fos induction by histamine appears to vary with
cell type.This is possibly due to the cell type speci¢city in relative
expression of histamine receptor isotypes and the amounts, activ-
ities, or receptor-coupling status of G-protein subfamilies.
MEK1 inhibitor PD98059 completely inhibited histamine-
induced c-Fos expression whereas its inhibition on NGF pro-
duction and AP-1 transcriptional activity was incomplete (Fig
7). On the other hand, these were completely inhibited by PKC
inhibitor calphostin C (Fig 7). This indicates that PKC may
c-Fos- and ERK-independently stimulate AP-1 activity and
NGF production. PKC is known to enhance the DNA binding
Figure 8. The histamine-induced e¡ects on PKC. (a) Keratinocytes
were incubated with medium alone or with 10^6 M histamine (HA) for 10
min. PKC activity was measured in cytosolic and membrane fractions. The
data are mean7SEM of ¢ve separate experiments. po0.05 versus control
values (Con), by paired t test. (b) Keratinocytes were preincubated with
pyrilamine (PR; 10^5 M, 30 min), cimetidine (CM; 10^5 M, 30 min),
U73122 (10^6 M, 30 min), or pertussis toxin (PTX; 100 ng per ml, 16 h),
and then incubated with 10^6 M histamine (HA) for 10 min. PKC activity
in the membrane fraction was analyzed. The data are mean7SEM of ¢ve
separate experiments. po0.05 versus control values with medium alone,
wpo0.05 versus values with histamine alone, by one-way ANOVA with
Sche¡e’s multiple comparison test.
Figure 9. The e¡ects of histamine on ERK1/2 (a), JNK (b), or p38
MAPK (c) phosphorylation. Keratinocytes were preincubated with 10^5
M pyrilamine (PR), 10^6 M calphostin C (CalC), 10^5 M PD98059, or 10^6
M AG1478 for 30 min, and then incubated with 10^6 M histamine (HA) for
10 min. Crude protein extracts (50 mg) were subjected to SDS-PAGE fol-
lowed by western blot analysis. The membranes were blotted with anti-
phospho-ERK antibody (upper panel), and then stripped and reprobed
with anti-ERK antibody (lower panel). (b), (c) Keratinocytes were incubated
with 10^6 M histamine for 10 min, and cellular protein extracts were
probed with antiphospho-JNK (b) or antiphospho-p38 antibody (c) (upper
panels), and then reprobed with anti-JNK or anti-p38 antibodies (lower pa-
nels), respectively. As a positive control, keratinocytes were incubated with
10 ng per ml tumor necrosis factor a (TNF-a) for 10 min, and were ana-
lyzed as above. The results shown in the ¢gure are representative of ¢ve
separate experiments.
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activity of c-Jun by dephosphorylating serine residues adjacent
to the DNA binding domain (Boyle et al, 1991; Goode et al,
1992), which may be the e¡ect independent from ERK and
c-Fos.
In contrast to c-Fos, c-Jun mRNA level was not increased by
histamine (Fig 6), which may be because histamine failed to acti-
vate JNK (Fig 9b), which phosphorylates c-Jun at N-terminal
serine residues. c-jun promoter contains atypical TRE where
c-Jun/activating transcription factor 2 heterodimer constitutively
binds, and phosphorylation of the heterodimer by JNK enhances
c-jun transcription (Karin, 1995). Though JNK increases transcrip-
tional activity of c-Jun, JNK may not be involved in histamine-
induced activation of AP-1 in keratinocytes. Robinson and
Dickenson (2001) also reported that histamine did not activate
JNK in hamster smooth muscle cell line DDT1MF-2. On the
other hand, histamine activated JNK in H2-receptor-transfected
human embryonic kidney cells (Wang et al, 2000). Thus JNK reg-
ulation via H1 or H2 receptor may vary depending on cell type.
The level of endogenous histamine produced by keratinocytes
was less than threshold (10^7 M) for NGF induction. More than
threshold level of histamine in vivo may possibly be derived from
mast cells accumulated in the dermis of in£ammatory skin
lesions. Thus histamine released from mast cells may induce
keratinocytes to produce NGF, and the induced NGF may in
turn promote histamine release from mast cells. Such a positive
feedback loop of histamine/NGFmay amplify in vivo skin in£ammat-
ion as NGF induces neurons to synthesize immunomodulatory
neuropeptides like substance P or calcitonin-gene-related peptide
(Linsay and Harmar, 1989), or induces keratinocytes to produce
in£ammatory cytokines or chemokines (Raychaudhuri et al,
2000), or enhances the survival or proliferation of neutrophils
and T cells (Toyoda et al, 2002). H1 receptor antagonist may inhi-
bit histamine-induced NGF production and thus block the
in£ammation, epidermal hyperplasia, and hyperinnervation
in in£ammatory skin lesions like psoriasis, atopic dermatitis,
or allergic contact dermatitis. As coculture with murine 3T3
¢broblasts increased constitutive NGF secretion by human
keratinocytes approximately 8-fold compared to controls in our
preliminary experiments, we are now studying whether hista-
mine may also increase NGF production in the coculture system,
which is more relevant to in vivo skin morphology.
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